Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check5 days agoChange DetectedA new PubMed citation has been added to Publications for DESTINY-PanTumor02, describing antitumor activity and biomarker analyses in HER2-expressing gynecologic cancers. This expands the study's related literature tied to the trial without changing any study details.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.5.4 has been added, replacing Revision: v3.5.3. This reflects an update to the site's versioning metadata and does not change the study details.SummaryDifference0.0%

- Check20 days agoChange DetectedNothing changed according to the provided changes data. There are no additions or deletions to interpret, so the page content remains as published.SummaryDifference0.0%

- Check27 days agoChange DetectedThe Taiwan site entry has been updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333. This change clarifies the city designation while preserving the postal code.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a site version update.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Gurgaon, India, 122001 and Revision: v3.5.2. Deleted Gūrgaon, India, 122001 and Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.